{
    "1683360221102739456": {
        "attachments": {
            "media_keys": [
                "13_1683360172733767681"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-07-24T06:15:26.000Z",
        "edit_history_tweet_ids": [
            "1683360221102739456"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 59,
                    "normalized_text": "HIV",
                    "probability": 0.7388,
                    "start": 57,
                    "type": "Other"
                },
                {
                    "end": 105,
                    "normalized_text": "HIV",
                    "probability": 0.9518,
                    "start": 103,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 5,
                    "start": 0,
                    "tag": "News"
                },
                {
                    "end": 16,
                    "start": 10,
                    "tag": "Media"
                },
                {
                    "end": 31,
                    "start": 21,
                    "tag": "Investors"
                }
            ],
            "mentions": [
                {
                    "end": 40,
                    "id": "3019793950",
                    "start": 33,
                    "username": "ViiVHC"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.com/en-gb/media/",
                    "end": 167,
                    "expanded_url": "https://www.gsk.com/en-gb/media/",
                    "start": 144,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/media/",
                    "url": "https://t.co/J2YRq145td"
                },
                {
                    "display_url": "pic.twitter.com/llNWruCa4L",
                    "end": 191,
                    "expanded_url": "https://twitter.com/GSK/status/1683360221102739456/video/1",
                    "media_key": "13_1683360172733767681",
                    "start": 168,
                    "url": "https://t.co/llNWruCa4L"
                }
            ]
        },
        "id": "1683360221102739456",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 5067,
            "like_count": 9,
            "quote_count": 0,
            "reply_count": 2,
            "retweet_count": 1
        },
        "text": "#News for #Media and #Investors: @ViiVHC, our specialist HIV company, has announced an update on their HIV prevention regimen. \n\nFind out more: https://t.co/J2YRq145td https://t.co/llNWruCa4L"
    }
}